Minomic

16 articles about Minomic

• Minomic Announces Completion of Demerger of GlyTherix Ltd

  9/25/2018

  Demerger clears the path for therapeutic company capital raising

• Minomic Secures Key Patent in the United States and China

  9/5/2018

  Minomic has received a Notice of Allowance for the company’s patent covering its cell surface antigen for the diagnosis of prostate cancer

• Minomic Announces Completion of Accrual for Clinical Study of Miltuximab® in Prostate, Bladder and Pancreatic Cancers

  7/25/2018

  No Drug-Related Adverse Effects Found in Patients

• Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer

  5/17/2018

  Australian immuno-oncology company Minomic International Ltd is pleased to announce the completion of its prospective clinical trial of the company’s novel prostate cancer diagnostic test, MiCheck®.

• Minomic Launches U.S. Prospective Study Of Micheck Prostate Cancer Test

  7/17/2017

• Minomic Clinical Study Progresses For Miltuximabtm In Prostate, Bladder, And Pancreatic Cancer

  6/29/2017

• Minomic Announces Clinical Study Update For MILGa In Prostate, Bladder And Pancreatic Cancers

  1/6/2017

• Minomic Announces Completion Of Oversubscribed Capital Raising At AGM

  12/1/2016

• Minomic: Agreement To Begin First-In-Human Trial Of Novel Prostate Cancer Imaging Agent

  10/22/2015

• Minomic Release: New Australian Prostate Cancer Diagnostic Technology To Feature At International Urology Conference

  5/14/2015

• Minomic Release: New Australian Prostate Cancer Diagnostic Technology To Feature At International Urology Conference

  5/14/2015

• Minomic Release: New Australian Prostate Cancer Screening Technology Achieves "Outstanding" Results On Key US Pilot Study

  4/20/2015

• Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology

  9/18/2014

• Minomic: Collaboration With U.S. Partner For New Prostate Cancer Treatment

  8/29/2014

• Minomic To Register Mistat ™ELISA Prostate Cancer Test For CE Mark Approval

  5/27/2014

• Minomic To Commence Two US Trials Of New Prostate Cancer Screening Technology, Mistat™

  4/9/2014